0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artesunate Medicines Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-25Q5700
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Artesunate Medicines Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Artesunate Medicines Market Research Report 2025

Code: QYRE-Auto-25Q5700
Report
July 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artesunate Medicines Market Size

The global market for Artesunate Medicines was valued at US$ 195 million in the year 2024 and is projected to reach a revised size of US$ 315 million by 2031, growing at a CAGR of 7.2% during the forecast period.

Artesunate Medicines Market

Artesunate Medicines Market

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artesunate Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artesunate Medicines.
The Artesunate Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artesunate Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artesunate Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Artesunate Medicines Market Report

Report Metric Details
Report Name Artesunate Medicines Market
Accounted market size in year US$ 195 million
Forecasted market size in 2031 US$ 315 million
CAGR 7.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Artesunate Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Artesunate Medicines Market growing?

Ans: The Artesunate Medicines Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the Artesunate Medicines Market size in 2031?

Ans: The Artesunate Medicines Market size in 2031 will be US$ 315 million.

Who are the main players in the Artesunate Medicines Market report?

Ans: The main players in the Artesunate Medicines Market are Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare

What are the Application segmentation covered in the Artesunate Medicines Market report?

Ans: The Applications covered in the Artesunate Medicines Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Artesunate Medicines Market report?

Ans: The Types covered in the Artesunate Medicines Market report are Monoaromatic Artesunate, Compound Artesunate

Recommended Reports

Antimalarial & Infectious

Chronic Disease Drugs

Oncology & Immunotherapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artesunate Medicines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoaromatic Artesunate
1.2.3 Compound Artesunate
1.3 Market by Application
1.3.1 Global Artesunate Medicines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artesunate Medicines Market Perspective (2020-2031)
2.2 Global Artesunate Medicines Growth Trends by Region
2.2.1 Global Artesunate Medicines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artesunate Medicines Historic Market Size by Region (2020-2025)
2.2.3 Artesunate Medicines Forecasted Market Size by Region (2026-2031)
2.3 Artesunate Medicines Market Dynamics
2.3.1 Artesunate Medicines Industry Trends
2.3.2 Artesunate Medicines Market Drivers
2.3.3 Artesunate Medicines Market Challenges
2.3.4 Artesunate Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artesunate Medicines Players by Revenue
3.1.1 Global Top Artesunate Medicines Players by Revenue (2020-2025)
3.1.2 Global Artesunate Medicines Revenue Market Share by Players (2020-2025)
3.2 Global Artesunate Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artesunate Medicines Revenue
3.4 Global Artesunate Medicines Market Concentration Ratio
3.4.1 Global Artesunate Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artesunate Medicines Revenue in 2024
3.5 Global Key Players of Artesunate Medicines Head office and Area Served
3.6 Global Key Players of Artesunate Medicines, Product and Application
3.7 Global Key Players of Artesunate Medicines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artesunate Medicines Breakdown Data by Type
4.1 Global Artesunate Medicines Historic Market Size by Type (2020-2025)
4.2 Global Artesunate Medicines Forecasted Market Size by Type (2026-2031)
5 Artesunate Medicines Breakdown Data by Application
5.1 Global Artesunate Medicines Historic Market Size by Application (2020-2025)
5.2 Global Artesunate Medicines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artesunate Medicines Market Size (2020-2031)
6.2 North America Artesunate Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artesunate Medicines Market Size by Country (2020-2025)
6.4 North America Artesunate Medicines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artesunate Medicines Market Size (2020-2031)
7.2 Europe Artesunate Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artesunate Medicines Market Size by Country (2020-2025)
7.4 Europe Artesunate Medicines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artesunate Medicines Market Size (2020-2031)
8.2 Asia-Pacific Artesunate Medicines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artesunate Medicines Market Size by Region (2020-2025)
8.4 Asia-Pacific Artesunate Medicines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artesunate Medicines Market Size (2020-2031)
9.2 Latin America Artesunate Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artesunate Medicines Market Size by Country (2020-2025)
9.4 Latin America Artesunate Medicines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artesunate Medicines Market Size (2020-2031)
10.2 Middle East & Africa Artesunate Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artesunate Medicines Market Size by Country (2020-2025)
10.4 Middle East & Africa Artesunate Medicines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Details
11.1.2 Fosun Pharma (Guilin) Business Overview
11.1.3 Fosun Pharma (Guilin) Artesunate Medicines Introduction
11.1.4 Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2020-2025)
11.1.5 Fosun Pharma (Guilin) Recent Development
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Details
11.2.2 Ipca Laboratories Business Overview
11.2.3 Ipca Laboratories Artesunate Medicines Introduction
11.2.4 Ipca Laboratories Revenue in Artesunate Medicines Business (2020-2025)
11.2.5 Ipca Laboratories Recent Development
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Details
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Artesunate Medicines Introduction
11.3.4 Sanofi Aventis Revenue in Artesunate Medicines Business (2020-2025)
11.3.5 Sanofi Aventis Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Details
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Artesunate Medicines Introduction
11.4.4 Ajanta Pharma Revenue in Artesunate Medicines Business (2020-2025)
11.4.5 Ajanta Pharma Recent Development
11.5 Shin Poong
11.5.1 Shin Poong Company Details
11.5.2 Shin Poong Business Overview
11.5.3 Shin Poong Artesunate Medicines Introduction
11.5.4 Shin Poong Revenue in Artesunate Medicines Business (2020-2025)
11.5.5 Shin Poong Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Artesunate Medicines Introduction
11.6.4 Cipla Revenue in Artesunate Medicines Business (2020-2025)
11.6.5 Cipla Recent Development
11.7 Acino
11.7.1 Acino Company Details
11.7.2 Acino Business Overview
11.7.3 Acino Artesunate Medicines Introduction
11.7.4 Acino Revenue in Artesunate Medicines Business (2020-2025)
11.7.5 Acino Recent Development
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Details
11.8.2 MCW Healthcare Business Overview
11.8.3 MCW Healthcare Artesunate Medicines Introduction
11.8.4 MCW Healthcare Revenue in Artesunate Medicines Business (2020-2025)
11.8.5 MCW Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Artesunate Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoaromatic Artesunate
 Table 3. Key Players of Compound Artesunate
 Table 4. Global Artesunate Medicines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Artesunate Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Artesunate Medicines Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Artesunate Medicines Market Share by Region (2020-2025)
 Table 8. Global Artesunate Medicines Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Artesunate Medicines Market Share by Region (2026-2031)
 Table 10. Artesunate Medicines Market Trends
 Table 11. Artesunate Medicines Market Drivers
 Table 12. Artesunate Medicines Market Challenges
 Table 13. Artesunate Medicines Market Restraints
 Table 14. Global Artesunate Medicines Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Artesunate Medicines Market Share by Players (2020-2025)
 Table 16. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Medicines as of 2024)
 Table 17. Ranking of Global Top Artesunate Medicines Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Artesunate Medicines Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Artesunate Medicines, Headquarters and Area Served
 Table 20. Global Key Players of Artesunate Medicines, Product and Application
 Table 21. Global Key Players of Artesunate Medicines, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Artesunate Medicines Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Artesunate Medicines Revenue Market Share by Type (2020-2025)
 Table 25. Global Artesunate Medicines Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Artesunate Medicines Revenue Market Share by Type (2026-2031)
 Table 27. Global Artesunate Medicines Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Artesunate Medicines Revenue Market Share by Application (2020-2025)
 Table 29. Global Artesunate Medicines Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Artesunate Medicines Revenue Market Share by Application (2026-2031)
 Table 31. North America Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Artesunate Medicines Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Artesunate Medicines Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Artesunate Medicines Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Artesunate Medicines Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Artesunate Medicines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Artesunate Medicines Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Artesunate Medicines Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Artesunate Medicines Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Artesunate Medicines Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Artesunate Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Artesunate Medicines Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Artesunate Medicines Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Fosun Pharma (Guilin) Company Details
 Table 47. Fosun Pharma (Guilin) Business Overview
 Table 48. Fosun Pharma (Guilin) Artesunate Medicines Product
 Table 49. Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 50. Fosun Pharma (Guilin) Recent Development
 Table 51. Ipca Laboratories Company Details
 Table 52. Ipca Laboratories Business Overview
 Table 53. Ipca Laboratories Artesunate Medicines Product
 Table 54. Ipca Laboratories Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 55. Ipca Laboratories Recent Development
 Table 56. Sanofi Aventis Company Details
 Table 57. Sanofi Aventis Business Overview
 Table 58. Sanofi Aventis Artesunate Medicines Product
 Table 59. Sanofi Aventis Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 60. Sanofi Aventis Recent Development
 Table 61. Ajanta Pharma Company Details
 Table 62. Ajanta Pharma Business Overview
 Table 63. Ajanta Pharma Artesunate Medicines Product
 Table 64. Ajanta Pharma Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 65. Ajanta Pharma Recent Development
 Table 66. Shin Poong Company Details
 Table 67. Shin Poong Business Overview
 Table 68. Shin Poong Artesunate Medicines Product
 Table 69. Shin Poong Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 70. Shin Poong Recent Development
 Table 71. Cipla Company Details
 Table 72. Cipla Business Overview
 Table 73. Cipla Artesunate Medicines Product
 Table 74. Cipla Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 75. Cipla Recent Development
 Table 76. Acino Company Details
 Table 77. Acino Business Overview
 Table 78. Acino Artesunate Medicines Product
 Table 79. Acino Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 80. Acino Recent Development
 Table 81. MCW Healthcare Company Details
 Table 82. MCW Healthcare Business Overview
 Table 83. MCW Healthcare Artesunate Medicines Product
 Table 84. MCW Healthcare Revenue in Artesunate Medicines Business (2020-2025) & (US$ Million)
 Table 85. MCW Healthcare Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Artesunate Medicines Picture
 Figure 2. Global Artesunate Medicines Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Artesunate Medicines Market Share by Type: 2024 VS 2031
 Figure 4. Monoaromatic Artesunate Features
 Figure 5. Compound Artesunate Features
 Figure 6. Global Artesunate Medicines Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Artesunate Medicines Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Other Case Studies
 Figure 11. Artesunate Medicines Report Years Considered
 Figure 12. Global Artesunate Medicines Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Artesunate Medicines Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Artesunate Medicines Market Share by Region: 2024 VS 2031
 Figure 15. Global Artesunate Medicines Market Share by Players in 2024
 Figure 16. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Medicines as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Artesunate Medicines Revenue in 2024
 Figure 18. North America Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Artesunate Medicines Market Share by Country (2020-2031)
 Figure 20. United States Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Artesunate Medicines Market Share by Country (2020-2031)
 Figure 24. Germany Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Artesunate Medicines Market Share by Region (2020-2031)
 Figure 32. China Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Artesunate Medicines Market Share by Country (2020-2031)
 Figure 40. Mexico Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Artesunate Medicines Market Share by Country (2020-2031)
 Figure 44. Turkey Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Artesunate Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Fosun Pharma (Guilin) Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 48. Ipca Laboratories Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 49. Sanofi Aventis Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 50. Ajanta Pharma Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 51. Shin Poong Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 52. Cipla Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 53. Acino Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 54. MCW Healthcare Revenue Growth Rate in Artesunate Medicines Business (2020-2025)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart